Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 12, 2012 - Issue 9
Submit an article Journal homepage
367
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluations

Bevacizumab treatment of prostate cancer

Alexander C SmallMount Sinai School of Medicine, Division of Hematology and Medical Oncology, 1 Gustave L Levy Place, Box 1128, New York, 10029, [email protected]
, BA &
William K OhMount Sinai School of Medicine, Division of Hematology and Medical Oncology, 1 Gustave L Levy Place, Box 1128, New York, 10029, [email protected]
Pages 1241-1249 | Published online: 09 Jul 2012

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Achuta Kumar Guddati. (2018) Current and potential targets for drug design in the androgen receptor pathway for prostate cancer. Expert Opinion on Drug Discovery 13:6, pages 489-496.
Read now

Articles from other publishers (15)

Mengdie Wang, Christi A. Wisniewski, Choua XiongPeter Chhoy, Hira Lal GoelAyush Kumar, Lihua Julie Zhu, Rui Li, Pamela A. St. LouisLindsay M. FerreiraHubert PakulaZhiwen Xu, Massimo Loda, Zhong JiangMichael A. Brehm & Arthur M. Mercurio. (2023) Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancer. Science Translational Medicine 15:694.
Crossref
Pierluigi Colli, Hector Gomez, Guillermo Lorenzo, Gabriela Marinoschi, Alessandro Reali & Elisabetta Rocca. (2021) Optimal control of cytotoxic and antiangiogenic therapies on prostate cancer growth. Mathematical Models and Methods in Applied Sciences 31:07, pages 1419-1468.
Crossref
Pierluigi Colli, Hector Gomez, Guillermo Lorenzo, Gabriela Marinoschi, Alessandro Reali & Elisabetta Rocca. (2020) Mathematical analysis and simulation study of a phase-field model of prostate cancer growth with chemotherapy and antiangiogenic therapy effects. Mathematical Models and Methods in Applied Sciences 30:07, pages 1253-1295.
Crossref
William L. Harryman, Noel A. Warfel, Raymond B. Nagle & Anne E. Cress. 2019. Prostate Cancer. Prostate Cancer 149 170 .
Teng Ma, Shaolin Yang, Haiyan Jing, Lin Cong, Zhixin Cao, Zhiling Liu & Zhaoqin Huang. (2018) Apparent diffusion coefficients in prostate cancer: correlation with molecular markers Ki-67, HIF-1α and VEGF. NMR in Biomedicine 31:3, pages e3884.
Crossref
Claudia Kessler, Alessa Pardo, Mehmet K. Tur, Stefan Gattenlöhner, Rainer Fischer, Katharina Kolberg & Stefan Barth. (2017) Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer. Journal of Cancer Research and Clinical Oncology 143:10, pages 2025-2038.
Crossref
Valérie Cochin, Marine Gross-Goupil, Alain Ravaud, Yann Godbert & Sylvestre Le Moulec. (2017) Cabozantinib : modalités d’action, efficacité et indications. Bulletin du Cancer 104:5, pages 393-401.
Crossref
Shaker A. Mousa & Paul J. Davis. 2017. Anti-Angiogenesis Strategies in Cancer Therapeutics. Anti-Angiogenesis Strategies in Cancer Therapeutics 1 19 .
Simone de Brot, Atara Ntekim, Ryan Cardenas, Victoria James, Cinzia Allegrucci, David M Heery, David O Bates, Niels Ødum, Jenny L Persson & Nigel P Mongan. (2015) Regulation of vascular endothelial growth factor in prostate cancer. Endocrine-Related Cancer 22:3, pages R107-R123.
Crossref
Fei Lian, Nitya V. Sharma, Josue D. Moran & Carlos S. Moreno. (2015) The biology of castration-resistant prostate cancer. Current Problems in Cancer 39:1, pages 17-28.
Crossref
F. Stephen Hodi, Donald Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada, Wanyong Zeng, Anita Giobbie-Hurder, Michael B. Atkins, Nageatte Ibrahim, Philip Friedlander, Keith T. Flaherty, George F. Murphy, Scott Rodig, Elsa F. Velazquez, Martin C. MihmJrJr, Sara Russell, Pamela J. DiPiro, Jeffrey T. Yap, Nikhil Ramaiya, Annick D. Van den Abbeele, Maria Gargano & David McDermott. (2014) Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma. Cancer Immunology Research 2:7, pages 632-642.
Crossref
Pamela H.S. TanSu Shin ChiaSiew Lok TohJames C.H. GohSaminathan Suresh Nathan. (2014) The Dominant Role of IL-8 as an Angiogenic Driver in a Three-Dimensional Physiological Tumor Construct for Drug Testing . Tissue Engineering Part A 20:11-12, pages 1758-1766.
Crossref
Holly M. Nguyen, Nazanin Ruppender, Xiaotun Zhang, Lisha G. Brown, Ted S. Gross, Colm Morrissey, Roman Gulati, Robert L. Vessella, Frauke Schimmoller, Dana T. Aftab & Eva Corey. (2013) Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling. PLoS ONE 8:10, pages e78881.
Crossref
Michael T. Schweizer & Michael A. Carducci. (2013) From Bevacizumab to Tasquinimod. The Cancer Journal 19:1, pages 99-106.
Crossref
Shaker A. Mousa. 2013. Angiogenesis Modulations in Health and Disease. Angiogenesis Modulations in Health and Disease 95 106 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.